Works matching IS 00042927 AND DT 2021 AND VI 62 AND IP 4
Results: 10
General aspects about Allium sativum – a review.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 471, doi. 10.30827/ars.v62i4.20843
- By:
- Publication type:
- Article
Avances en las formulaciones de los antisépticos.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 451, doi. 10.30827/ars.v62i4.21804
- By:
- Publication type:
- Article
Secreted Frizzled – Related Protein 4 y el cáncer de mama.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 438, doi. 10.30827/ars.v62i4.21740
- By:
- Publication type:
- Article
¿Reducen las estatinas el riesgo de glaucoma? revisión de las evidencias.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 419, doi. 10.30827/ars.v62i4.21463
- By:
- Publication type:
- Article
Consecuencias derivadas de la automedicación con benzodiacepinas en personas adultas: revisión exploratoria.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 404, doi. 10.30827/ars.v62i4.21614
- By:
- Publication type:
- Article
Resistencia a los anticuerpos monoclonales anti-EGFR en el tratamiento del carcinoma de cabeza y cuello.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 389, doi. 10.30827/ars.v62i4.20980
- By:
- Publication type:
- Article
Medicamentos de elaboración o preparación no industrial: una nueva propuesta de clasificación.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 379, doi. 10.30827/ars.v62i4.21094
- By:
- Publication type:
- Article
La farmacéutica Milagro Almenara Pérez, del olvido a su reconocimiento.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 371, doi. 10.30827/ars.v62i4.21442
- By:
- Publication type:
- Article
Antiradical and antiulcer effect of Sonneratia apetala Buch-Ham leaves against alcohol induced gastric mucosal injury.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 348, doi. 10.30827/ars.v62i4.20759
- By:
- Publication type:
- Article
Comparison of in vitro, in vivo, and in silico bioavailability results of different prednisone tablet formulations to assess the feasibility of possible biowaiver.
- Published in:
- Ars Pharmaceutica, 2021, v. 62, n. 4, p. 358, doi. 10.30827/ars.v62i4.21029
- By:
- Publication type:
- Article